The Sub-Directorate: Vector-Borne Diseases is responsible for prevention and control of specific Vector-Borne diseases and to ensure a pro-active, appropriate and effective response to these diseases in the interest of the public in South Africa.
Key areas:
Malaria is a disease caused mainly by the parasite Plasmodium falciparum. There are 3 other parasite species (malariae, vivax and ovale) that also cause malaria but they are rare in South Africa. The parasite is transmitted to humans by a vector viz, the female anopheles mosquito.
Malaria is mainly transmitted in the low altitude areas of the northeastern parts of South Africa; this includes the lowveld region of Mpumalanga, Northern Province and the northeastern parts of Kwa-Zulu Natal (fig 1 - risk areas)
Malaria transmission in South Africa is seasonal with the greatest number of cases occurring between October and May.
Mosquitoes' vectorial capacity to transmit malaria lies in the obligatory blood feeding habit of female mosquitoes an their close association with humans and their habitations. In South Africa malaria transmission is by two anopheline species, Anopheles arabiensis and Anopheles funestus group, respectively. As a result thorough knowledge of identity and biology of malaria vectors is central to effective and efficient targeted vector control.
The mainstay of the malaria control programme in South Africa is through insecticide residual house spraying.
With the advent of malaria drug resistance, prompt diagnosis is a crucial component of malaria control and patient management. The gold standard for the laboratory diagnosis of Malaria remains the microscopic test, through the examination of stained thin and thick blood films. However due to the urgency of obtaining a diagnosis and the expertise required to examine blood films, alternative methods for diagnosing malaria have been developed. These are the antigen detection tests, commonly referred to as Rapid Malaria Diagnostic tests (or the rapid card tests). The merit of this technology does not require experienced personnel and the tests can be conducted at the clinics in the malaria endemic areas. The principle of the test relies on the capture of the Plasmoduim falciparum histidine rich protein (HRP), which is secreted by infected red cells. This antigen can be detected in red blood cells, serum, plasma cerebrospinal fluid and urine of patients infected with P. falciparum malaria.
There are other highly accurate, sophisticated methods used for malaria diagnosis, but most of these require experienced laboratory technicians and are expensive, thus prohibiting its use in the endemic areas. These tests include the Quantitative Buffy Coat (QBC) and Polymerase Chain Reaction (PCR).

Note: these guidelines were published in 1996, and will be updated shortly
You can find the guidelines at www.malaria.org.za
The guidelines are endorsed by the Medical Association of South Africa.
Compiled by the Department of Health in collaboration with the
Subcommittee for Chemoprophylaxis and Therapy of the National Malaria
Advisory Group.
October 1996
D. Moonasar ; National Department of Health, Sub Directorate Vector Borne Diseases, Private Bag X 828, Pretoria 0001, South Africa, Hallmark 1838, Tel: +12 3120102 Fax: +12 3238626, Email moonad@health.gov.za
Dr Frank Hansford, Senior Medical Officer, Malaria Expert, Department of Health and Welfare Northern Province Tzaneen 0850, Tel 015 3071663, FAX 015 3071663, email mwtrong@mweb.co.za
Links